Zydus Cadila gets US health regulator nod for multiple sclerosis treatment drugZydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Dimethyl Fumarate delayed re...
25 Sep, 2020, 11.22 AM IST
Dow Jones muted as virus cases rise, jobless claims weighDow Jones Industrial Average was down 2.98 points, or 0.01 per cent, at 26,116.63.
18 Jun, 2020, 09.56 PM IST
Glenmark gets tentative nod from USFDA for generic multiple sclerosis treatment drugThese are generic version of Tecfidera Capsules, 120 mg and 240 mg, of Biogen Inc.
09 Oct, 2019, 01.00 PM IST
Shilpa Medicare gets tentative USFDA nod for multiple sclerosis drugThe company's abbreviated new drug application (ANDA) for Dimethyl Fumarate delayed release capsules in the strengths of 120 mg and 240 mg ...
16 Nov, 2018, 02.03 PM IST
Biogen Idec gets DCGI nod for multiple sclerosis oral drugThe company has received approval for the first oral therapy drug Tecfidera for multiple sclerosis by DCGI, Biogen Idec Biotech India Pvt L...
12 Feb, 2015, 05.55 PM IST